Latest Breaking News On - Deciphera pharmaceutical qinlock - Page 1 : comparemela.com

The company is conducting a clinical trial of a pan-variant inhibitor for KIT-mutant GIST and hopes to advance an EGFR pan-variant inhibitor to the clinic soon.

United statesUnited kingdomNovarti gleevecBoehringer ingelheim gilotrifTim clacksonBayer stivargaGenentech tarcevaAstrazeneca tagrissoAmerican association for cancer researchTheseus pharmaceuticalsAriad pharmaceuticalsBlueprint medicine ayvakitDeciphera pharmaceutical qinlockBoehringer ingelheimAmerican associationCancer research